Community Oncology Alliance

 

2021 Community Oncology Conference
A

Hospital Drug Pricing: Is Pricing Transparency Going to Change the Current Situation? Should Drugs Be Shifted Out of Hospitals? Are Biosimilars More Likely to Be Adopted?

By 2021 Community Oncology Conference FEATURING Aharon Gal
By 2021 Community Oncology Conference FEATURING Aharon Gal
9 views
April 28, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

11:42
ImmunoGen

Best Practices for the management of ocular adverse events associate…

Feat. K. Lamoreau

Featured Video

19:51
AstraZeneca Oncology

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn
2021 Community Oncology Conference
12:52
2021 Community Oncology Conference

Opportunities & Challenges in TNBC: Navigating Immune CPI Effica…

Feat. J. O'Shaughnessy
15:12
2021 Community Oncology Conference

Advances in HER2+ BC: Overview of Current Data

Feat. J. O'Shaughnessy
08:18
2021 Community Oncology Conference

2021 Update on Frontline CLL: Comparing Treatment Outcomes With BTK …

Feat. J. Sharman
17:51
2021 Community Oncology Conference

2021 Update on Targeting Pathways in Frontline CLL: BTK Resistance, …

Feat. J. Sharman
13:21
2021 Community Oncology Conference

New Advances in KRASm NSCLC: Considering Sotorasib & Adagrasib E…

Feat. A. Spira
14:20
2021 Community Oncology Conference

2021 Update on EGFR Exon20ins in mNSCLC: Bispecific Antibody vs. TKI…

Feat. A. Spira
08:19
2021 Community Oncology Conference

2021 Data on HCC & mCRC: Atezo+Bev vs. Sorafenib in Unresectable…

Feat. J. Bendell
05:11
2021 Community Oncology Conference

2021 Biliary Tract Cancer Updates: Ivosidenib in Chemo-Refractory ID…

Feat. J. Bendell
05:17
2021 Community Oncology Conference

2021 Pancreatic Cancer Updates: Preoperative mFOLFIRINOX vs. Gem/nab…

Feat. J. Bendell
08:38
2021 Community Oncology Conference

2021 GE Cancer Updates: Nivo for Stage 2/3 EC/GEJC, Chemo+/-Pembro i…

Feat. J. Bendell
02:31
2021 Community Oncology Conference

Guide to Current Biomarker Testing for GI Cancers and Improvements i…

Feat. J. Bendell
39:14
2021 Community Oncology Conference

New Coding & Reimbursement Changes in 2021: Best Practices, Medi…

Feat. J. Blakely, R. Buell, B. Gamble, B. McAneny
40:03
2021 Community Oncology Conference

How to Maximize Practice Efficiencies and Reduce Costs: What Your Pr…

Feat. B. Gamble, M. Neubauer, T. O’Connell, A. Rahman
21:33
2021 Community Oncology Conference

Hospital Drug Pricing: Is Pricing Transparency Going to Change the C…

Feat. A. Gal
34:38
2021 Community Oncology Conference

How Employers Approach Cancer Care & Benefit Design: Strategies,…

Feat. R. Baird, Jr., B. Jackson, R. Opdycke, C. Shaffer
29:26
2021 Community Oncology Conference

Ensuring & Measuring Quality With a New Model for Cancer Care: P…

Feat. M. Diaz, B. Gamble, L. Wilfong
28:47
2021 Community Oncology Conference

Palliative Care in Oncology: Can It Improve QoL and Reduce the Use o…

Feat. M. Rezaie
12:27
2021 Community Oncology Conference

2021 IO & Gene Therapy Updates: Cancer Medicine and Vaccines in …

Feat. D. Spigel
13:31
2021 Community Oncology Conference

2021 Updates on Theranostics in Oncology: How Do Diagnostic & Th…

Feat. T. Abraham
37:09
2021 Community Oncology Conference

Biomarker Testing Updates: NGS vs. CGP, Who to Test, Predictive Biom…

Feat. M. Dietrich, B. Green, G. Oxnard, A. Sireci, B. Yoon
38:48
2021 Community Oncology Conference

Biosimilars in Cancer Care: Challenges & Opportunities From Rese…

Feat. E. Randolph Broun, S. Oskouei, K. Oubre, S. Parsad
52:02
2021 Community Oncology Conference

COVID-19 Pandemic Management: How Has Cancer Care Evolved and Innova…

Feat. L. Gordan, J. Perry, J. Pichoske